KMT2A and acute myeloid leukemia: In line with the latter, it has been demonstrated that the hematopoietic transcription factor ZNF521 increases its levels in AML with MLL rearrangements, enhancing hematopoietic stem cell transformation via ZEB1, among other genes [145].